Aberrant HER2 signaling is a therapeutic target in a subset of castration-resistant prostate cancer

被引：0
|
作者：
Russo, Joshua W. [1 ]
Gao, Xin [2 ]
Einstein, David J. [1 ]
Bubley, Glenn J. [1 ]
Balk, Steven P. [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-395
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
395
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Kaiso as a novel therapeutic target in castration-resistant prostate cancer
    Lin, Huixian
    Wang, Honghe
    White, Jason
    Karanam, Balasubramanyam
    Ghebremedhin, Anghesom
    Adu-Addai, Benjaminal
    Grizzle, William
    Yates, Clayton
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
  • [2] Wnt Signaling and Therapeutic Resistance in Castration-Resistant Prostate Cancer
    Kishore, Chandra
    Zi, Xiaolin
    [J]. CURRENT PHARMACOLOGY REPORTS, 2023, 9 (05) : 261 - 274
  • [3] LINE-1 as a therapeutic target for castration-resistant prostate cancer
    Houede, Nadine
    Piazza, Pier Vincenzo
    Pourquier, Philippe
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2018, 23 : 1292 - 1309
  • [4] GALECTIN-3 IS A THERAPEUTIC TARGET FOR CASTRATION-RESISTANT PROSTATE CANCER
    Fukumori, Tomoharu
    Dondoo, Tsogt-Ochir
    Daizumoto, Kei
    Fukawa, Tomoya
    Yamamoto, Yasuyo
    Yamaguchi, Kunihisa
    Takahashi, Masayuki
    Kanayama, Hiro-omi
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E675 - E675
  • [5] MiRNA 34a: a therapeutic target for castration-resistant prostate cancer
    Chalanqui, Marine J.
    O'Doherty, Michelle
    Dunne, Nicholas J.
    McCarthy, Helen O.
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (09) : 1075 - 1085
  • [6] Kaiso as a novel therapeutic target in castration-resistant prostate cancer (CRPC)
    Lin, Hui-Xian
    Wang, Honghe
    White, Jason
    Karanam, Balasubramanyam
    Ghebremedhin, Anghesom
    Addai, Benjamin Adu
    Grizzle, William E.
    Yates, Clayton
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [7] PP2A inhibition as a novel therapeutic target in castration-resistant prostate cancer
    Gonzalez-Alonso, Paula
    Cristobal, Ion
    Manso, Rebeca
    Madoz-Gurpide, Juan
    Garcia-Foncillas, Jesus
    Rojo, Federico
    [J]. TUMOR BIOLOGY, 2015, 36 (08) : 5753 - 5755
  • [8] Repurposing CRISPR to study aberrant AR signaling in models of castration-resistant prostate cancer
    Kounatidou, Evangelia E.
    Robson, Craig
    Gaughan, Luke
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [9] Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer
    McLeod, Abigail B.
    Stice, James P.
    Wardell, Suzanne E.
    Alley, Holly M.
    Chang, Ching-yi
    McDonnell, Donald P.
    [J]. PROSTATE, 2018, 78 (04): : 266 - 277
  • [10] USP54 is a potential therapeutic target in castration-resistant prostate cancer
    Zhou, Cheng
    Zhang, Xuehu
    Ma, Hangbin
    Zhou, Yinghao
    Meng, Yibo
    Chen, Chenchen
    Shi, Guowei
    Yu, Wandong
    Zhang, Jun
    [J]. BMC UROLOGY, 2024, 24 (01)
12345